COVID-19:
COVID-19 public health information from the US CDC |
COVID-19 research information from the US NIH |
Español |
COVID-19 resources for global health researchers
Characterizing the Pharmacokinetics of High Dose Rifampicin and Linezolid in a Randomized Controlled Trial for HIV-associated Tuberculous Meningitis
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader